M.C. Pennucci

635 total citations
17 papers, 504 citations indexed

About

M.C. Pennucci is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, M.C. Pennucci has authored 17 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in M.C. Pennucci's work include Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Research Studies (6 papers) and Cancer therapeutics and mechanisms (5 papers). M.C. Pennucci is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Research Studies (6 papers) and Cancer therapeutics and mechanisms (5 papers). M.C. Pennucci collaborates with scholars based in Italy, Czechia and Netherlands. M.C. Pennucci's co-authors include Giorgio V. Scagliotti, Andrea Ardizzoni, G.S. Kho, Jan P. van Meerbeeck, Desmond Curran, Pieter E. Postmus, Q. van Hoesel, Ted A.W. Splinter, C. Debruyne and Nico van Zandwijk and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of the New York Academy of Sciences.

In The Last Decade

M.C. Pennucci

17 papers receiving 480 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.C. Pennucci Italy 9 355 287 93 41 34 17 504
Shiven B. Patel United States 12 168 0.5× 276 1.0× 106 1.1× 46 1.1× 23 0.7× 47 420
F. Figoli Italy 10 336 0.9× 363 1.3× 143 1.5× 62 1.5× 32 0.9× 29 554
M. Sassi Italy 7 345 1.0× 361 1.3× 65 0.7× 37 0.9× 16 0.5× 9 529
Matthew Perry United States 8 136 0.4× 294 1.0× 65 0.7× 63 1.5× 31 0.9× 13 458
C. Sessa Switzerland 10 91 0.3× 203 0.7× 122 1.3× 28 0.7× 19 0.6× 26 447
Kazimierz Roszkowski Poland 7 328 0.9× 298 1.0× 48 0.5× 14 0.3× 13 0.4× 19 421
Alison Norton United Kingdom 9 321 0.9× 305 1.1× 45 0.5× 20 0.5× 6 0.2× 10 420
Glen Goss Canada 11 174 0.5× 294 1.0× 138 1.5× 43 1.0× 12 0.4× 19 416
M. Kozloff United States 12 138 0.4× 273 1.0× 54 0.6× 11 0.3× 12 0.4× 29 352
Joshua J. McFarlane United States 7 96 0.3× 109 0.4× 43 0.5× 45 1.1× 38 1.1× 8 240

Countries citing papers authored by M.C. Pennucci

Since Specialization
Citations

This map shows the geographic impact of M.C. Pennucci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.C. Pennucci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.C. Pennucci more than expected).

Fields of papers citing papers by M.C. Pennucci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.C. Pennucci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.C. Pennucci. The network helps show where M.C. Pennucci may publish in the future.

Co-authorship network of co-authors of M.C. Pennucci

This figure shows the co-authorship network connecting the top 25 collaborators of M.C. Pennucci. A scholar is included among the top collaborators of M.C. Pennucci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.C. Pennucci. M.C. Pennucci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Pacetti, Paola, et al.. (2015). Chemotherapy in the last 30 days of life of advanced cancer patients. Supportive Care in Cancer. 23(11). 3277–3280. 40 indexed citations
2.
Fornaro, Lorenzo, Enrico Vasile, Carmelo Tibaldi, et al.. (2014). EGFR and K-Ras mutations in women with lung adenocarcinoma: implications for treatment strategy definition. Journal of Experimental & Clinical Cancer Research. 33(1). 77–77. 11 indexed citations
3.
Pezzuolo, Debora, et al.. (2010). Low Dose Fractionated Cisplatin Plus Gemcitabine for Elderly Patients with Advanced Non Small Cell Lung Cancer: A Retrospective Analysis. Journal of Chemotherapy. 22(4). 275–279. 2 indexed citations
4.
Tibaldi, Carmelo, Tiziana Prochilo, M.C. Pennucci, et al.. (2006). Epirubicin/paclitaxel/etoposide in extensive-stage small-cell lung cancer: a phase I–II study. British Journal of Cancer. 94(9). 1263–1266. 3 indexed citations
5.
Ardizzoni, Andrea, Giovanna Antonelli, Sante Basso Ricci, et al.. (2000). Ambamustine in the Second-Line Treatment of Patients With Small-Cell Lung Cancer. American Journal of Clinical Oncology. 23(1). 22–25. 7 indexed citations
6.
Marinis, Filippo de, Monica Rinaldi, Andrea Ardizzoni, et al.. (1999). The Role of Vindesine and Lonidamine in the Treatment of Elderly Patients with Advanced Non-small Cell Lung Cancer: A Phase III Randomized Fonicap Trial. Tumori Journal. 85(3). 177–182. 29 indexed citations
7.
Grossi, Francesco, M.C. Pennucci, Lucia Tixi, Mara A. Cafferata, & Andrea Ardizzoni. (1998). Management of Malignant Pleural Effusions. Drugs. 55(1). 47–58. 25 indexed citations
8.
9.
Pennucci, M.C., Andrea Ardizzoni, P. Pronzato, et al.. (1997). Combined cisplatin, doxorubicin, and mitomycin for the treatment of advanced pleural mesothelioma. Cancer. 79(10). 1897–1902. 33 indexed citations
10.
Boni, Luca, M.C. Pennucci, Andrea Ardizzoni, et al.. (1997). 9 Factors affecting response rate (RR) and survival (OS) in advanced non-small-cell lung cancer (NSCLC): Retrospective analysis on 1128 patients (pts). Lung Cancer. 18. 5–5. 1 indexed citations
11.
Loprevite, Maura, Roberto E. Favoni, Giovanni Battista Ferrara, et al.. (1997). Analysis of K-ras, p53, bcl-2 and Rb expression in non-small cell lung cancer cell lines. International Journal of Oncology. 11(6). 1203–8. 4 indexed citations
12.
Baldini, Editta, Andrea Ardizzoni, M.C. Pennucci, et al.. (1995). 1059 Cisplatin, Vindesine, Mitomycin (MVP) vs Cisplatin, Ifosfamide, Navelbine (PIN) vs Carboplatin, Navelbine (CAN) in advanced non-small cell lung cancer (NSCLC). European Journal of Cancer. 31. S221–S222. 1 indexed citations
13.
Ardizzoni, Andrea, M.C. Pennucci, B. Castagneto, et al.. (1994). Recombinant Interferon Alpha-2b in the Treatment of Diffuse Malignant Pleural Mesothelioma. American Journal of Clinical Oncology. 17(1). 80–82. 29 indexed citations
14.
Venturini, M., Lucia Del Mastro, Andrea Ardizzoni, et al.. (1993). High Dose Intensity Chemotherapy without Bone Marrow Support: Role of Granulocyte‐Macrophage Colony‐Stimulating Factora. Annals of the New York Academy of Sciences. 698(1). 389–397. 1 indexed citations
15.
16.
17.
Ardizzoni, Andrea, M.R. Sertoli, Anna Corcione, et al.. (1990). Accelerated chemotherapy with or without GM-CSF for small cell lung cancer: a non-randomised pilot study. European Journal of Cancer and Clinical Oncology. 26(9). 937–941. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shiven B. Patel Breakdown of academic impact, for papers by F. Figoli Breakdown of academic impact, for papers by M. Sassi Breakdown of academic impact, for papers by Matthew Perry Breakdown of academic impact, for papers by C. Sessa Breakdown of academic impact, for papers by Kazimierz Roszkowski Breakdown of academic impact, for papers by Alison Norton Breakdown of academic impact, for papers by Glen Goss Breakdown of academic impact, for papers by M. Kozloff Breakdown of academic impact, for papers by Joshua J. McFarlane
Rankless by CCL
2026